News releases from the National Institutes of Health (NIH)
Updated: 7 hours 44 min ago
Data from Phase 3 clinical trial confirm vaccine is effective.
Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.
Very low birthweight infants often need blood transfusions to survive.
NIH- and BARDA-funded trial will enroll up to 30,000 volunteers.
Metabolic syndrome affects about 25% of adults and is on the rise, and its prevalence is even greater among patients with psoriasis.
NIH-funded study suggests our brains may be more in tune with each other than we think.
NIH BRAIN Initiative scientists used machine learning to redesign a bacterial ‘Venus flytrap’ protein that can monitor brain serotonin levels in real time.
Experimental monoclonal antibody not efficacious in Phase 3 trial.
NIH-funded findings highlight need for clinical trials to determine best treatment options.
Anticoagulation drugs did not reduce the need for organ support.
NIH-funded findings also suggest less-than-expected transfer of maternal SARS-CoV-2 antibodies through placenta.
Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections.
NIH Clinical Center front-line workers, Azar, Collins, Fauci to receive doses from agency’s initial stock.
Finding reveals potential for spread to humans.
Awards part of a larger effort to study pediatric COVID-19 and related conditions.
RADx-rad program will fund non-traditional and repurposed technologies to combat the current pandemic and address future viral disease outbreaks.
The mRNA-1273 vaccine is the second COVID-19 vaccine in the United States to be granted an EUA.